July 9, 2014

Salix shares fall 3% after merger announcement

Shares of Salix Pharmaceuticals fell 3 percent Wednesday as investors gave a muted response to the Raleigh company’s plan to merge with an Italian drug company and reincorporate in Ireland in order to lower its tax rate.

Related content